Condition
Scalp Nerve Block
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
Early P 1 (1)
Trial Status
Unknown1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06720285Early Phase 1CompletedPrimary
The Efficacy of Regional Scalp Block in Craniotomy
NCT06157359Not ApplicableUnknown
Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection
NCT05556889Not ApplicableRecruiting
Safety and Analgesic Efficacy of a Modified Auriculotemporal Nerve Block
Showing all 3 trials